Medicare Enrolled
Dr. Julie Byrd, M.D.
Dermatology · Rochester Hills, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Byrd from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Byrd?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Byrd
Dr. Julie Byrd is a dermatology specialist in Rochester Hills, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Byrd performed 16,173 Medicare services across 5,623 unique beneficiaries.
Between the years covered by Open Payments, Dr. Byrd received a total of $36,592 from 54 pharmaceutical and/or device companies across 1062 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Byrd is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in MI
$36,592 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,173
Medicare services
Top 0% in MI for dermatology
5,623
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~851 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
5,629 | $5 | $10 |
| Photodynamic therapy gel for precancerous skin | 3,600 | $1 | $2 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,533 | $64 | $139 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
1,346 | $39 | $104 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
1,223 | $83 | $174 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
402 | $64 | $156 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
287 | $99 | $197 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
284 | $130 | $262 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
260 | $75 | $174 |
| Destruction of skin growth, 15 or more growths | 231 | $100 | $204 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
221 | $42 | $87 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
214 | $4 | $9 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
206 | $37 | $88 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
165 | $1 | $2 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
96 | $40 | $78 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
93 | $90 | $194 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
82 | $10 | $22 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
54 | $130 | $277 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
44 | $114 | $258 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
43 | $90 | $194 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
34 | $43 | $112 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
20 | $46 | $142 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
18 | $238 | $471 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
18 | $53 | $150 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
16 | $180 | $408 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
15 | $228 | $427 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
14 | $77 | $266 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 13 | $138 | $292 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
12 | $171 | $320 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$36,592
Total received (2018-2024)
Avg $5,227/year across 7 years
Top 8% in MI for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
1,062
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,366 (58.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,054 (41.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$172 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,209
2023
$7,090
2022
$5,065
2021
$4,571
2020
$1,846
2019
$4,685
2018
$5,126
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$3,908
SUN PHARMACEUTICAL INDUSTRIES INC.
$843
Dermavant Sciences, Inc.
$506
Janssen Biotech, Inc.
$426
E.R. Squibb & Sons, L.L.C.
$318
Regeneron Healthcare Solutions, Inc.
$272
Galderma Laboratories, L.P.
$222
Arcutis Biotherapeutics, Inc.
$196
Incyte Corporation
$188
LEO Pharma Inc.
$182
GENZYME CORPORATION
$178
Novartis Pharmaceuticals Corporation
$155
Lilly USA, LLC
$154
Biofrontera Inc.
$101
REVANCE THERAPEUTICS, INC.
$95
Amgen Inc.
$74
Journey Medical Corporation
$66
UCB, Inc.
$65
Boehringer Ingelheim Pharmaceuticals, Inc.
$60
PFIZER INC.
$53
Ortho Dermatologics, a division of Bausch Health US, LLC
$40
Organon Llc
$36
Almirall LLC
$30
STRATA Skin Sciences, Inc.
$25
Verrica Pharmaceuticals Inc.
$14
Top 3 companies account for 64.0% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$4,679
ABBVIE INC.
$4,280
PFIZER INC.
$3,011
Janssen Biotech, Inc.
$2,244
EPI Health, LLC
$2,190
Galderma Laboratories, L.P.
$2,174
AbbVie, Inc.
$1,871
Novartis Pharmaceuticals Corporation
$1,331
Journey Medical Corporation
$1,152
SUN PHARMACEUTICAL INDUSTRIES INC.
$1,086
Regeneron Healthcare Solutions, Inc.
$965
Sun Pharmaceutical Industries Inc.
$952
GENZYME CORPORATION
$947
Dermavant Sciences, Inc.
$878
Ortho Dermatologics, a division of Bausch Health US, LLC
$829
E.R. Squibb & Sons, L.L.C.
$687
Almirall LLC
$636
LEO Pharma Inc.
$622
Lilly USA, LLC
$611
Amgen Inc.
$607
UCB, Inc.
$576
Avita Medical Americas, LLC
$500
Incyte Corporation
$486
Arcutis Biotherapeutics, Inc.
$387
Allergan Inc.
$334
Merz North America, Inc.
$320
VYNE Pharmaceuticals Inc.
$319
Biofrontera Inc.
$293
Verrica Pharmaceuticals Inc.
$218
SANOFI-AVENTIS U.S. LLC
$217
Boehringer Ingelheim Pharmaceuticals, Inc.
$136
Mayne Pharma Inc.
$120
Encore Dermatology Inc.
$118
REVANCE THERAPEUTICS, INC.
$95
Genentech USA, Inc.
$81
Allergan, Inc.
$79
MAYNE PHARMA COMMERCIAL LLC
$72
Promius Pharma LLC
$65
Sandoz Inc.
$61
STRATA Skin Sciences, Inc.
$49
MAYNE PHARMA INC.
$41
Bayer HealthCare Pharmaceuticals Inc.
$38
Organon Llc
$36
Merck Sharp & Dohme Corporation
$35
PruGen, Inc. Pharmaceuticals
$34
Medimetriks Pharmaceuticals, Inc.
$28
Sebela Pharmaceuticals Inc.
$17
Integra LifeSciences Corporation
$15
Sensus Healthcare, Inc.
$13
Nabriva Therapeutics, plc
$12
Mylan Pharmaceuticals Inc.
$12
Novum Pharma, LLC
$12
Horizon Pharma plc
$11
DERMIRA, INC.
$11
Top 3 companies account for 32.7% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · APEXICON E · ARAZLO · Absorica LD · Acticlate · Aczone · Alcortin A · Ameluz · BOTOX · BOTOX COSMETIC · Bimzelx · CIBINQO · CLODERM · COSENTYX · CYLTEZO · Cabtreo · Ceracade · Cimzia · Cloderm Cream · Cordran Tape · DAXXIFY · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dermatological Psoriasis and Vitiligo Treatment · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · Exelderm · Finacea · HADLIMA · HUMIRA · Humira · ILUMYA · INTEGRA MESHED BILAYER WOUND MATRIX · Ilumya · Impoyz · JUBLIA · Klisyri · LIBTAYO · NAFTIN · Neo-Synalar Cream · OLUMIANT · OPZELURA · ORACEA · Olux · Otezla · QBREXZA · RAYOS · REMICADE · RETIN-A-MICRO · RINVOQ · Recell · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Sernivo · Seysara · Sitavig · Sivextro · Sotyktu · TALTZ · TREMFYA · TWYNEO · TargaDox · Tremfya · VTAMA · Veltin · Verdeso · WYNZORA · Winlevi · XEOMIN · XTRAC · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for dermatology in MI.
Geographic Context
Dermatologists within 10 mi
186
Per 100K population
14.6
County median income
$95,296
Nearest hospital
ASCENSION PROVIDENCE ROCHESTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Byrd is a mixed practice specialist, with above-average Medicare volume (top 0% in MI), with low-engagement industry engagement in the top 8% of MI peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Byrd experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Byrd performed 5,629 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Byrd receive payments from pharmaceutical companies?
Yes. Dr. Byrd received a total of $36,592 from 54 companies across 1,062 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Byrd's costs compare to other dermatologists in Rochester Hills?
Dr. Byrd's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Byrd) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Rochester Hills
Browse dermatologists in Rochester Hills ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in MI
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in MI
Which MI dermatologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology